Advertisement
Second (or third) time’s a charm in reducing splenomegaly and other symptoms
Study sheds light on value of genetic testing
Using data science to identify intrinsic patterns in cancer data
Slightly greater risk of bleeding
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
No evidence of residual tumor or recurrence at 6.5 years of follow-up
Study adds to guidance for urologists
A Q&A with Laura Shoemaker, DO
How one hematologist learned to use and value it
Biological potential of disease better informs AS candidacy
First-of-its kind study broadens understanding
Advertisement
Advertisement